Silence Therapeutics
NasdaqGM:SLN
$ 5,47
+ $0,27 (5,19%)
5,47 $
+$0,27 (5,19%)
End-of-day quote: 03/25/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,99
Earnings Per Share
$0,91
Revenue Per Share
72,70%
Gross Margin %
$0,25 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-0,99
Revenue Per Share
$0,91
Gross Margin %
72,70%
Market Cap
$0,25 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020
EPS Earnings Per Share $-0,99 $-0,99 $-1,49 $-1,53 $-1,74 $-1,64
Earnings Earnings $-46,76M $-46,75M $-69,29M $-55,00M $-52,08M $-45,54M
RPS Revenue Per Share $0,00 $0,91 $0,91 $0,55 $0,49 $0,41 $0,20
Revenue Revenue $0,00M $42,90M $42,90M $25,38M $17,50M $12,42M $5,48M
OCF Operating Cash Flow $0,00M $-67,08M $-67,08M $-39,35M $-45,46M $6,81M $-10,78M
FCF Free Cash Flow $0,00M $-83,04M $-67,29M $-36,50M $-45,60M $1,08M $-11,29M
OM Operating Margin 0,00% 0,00% -114,62% -165,70% -236,53% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 72,70% 59,34% 37,83% 39,94% 31,34%
FCFS Free Cash Flow Per Share $0,00 $0,00 $-1,47 $-1,33 $-1,79 $0,18 $-0,41
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 47,22M 47,23M 47,22M 46,5M 35,95M 29,93M 27,77M
×